Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
about
Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionMutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.Antimicrobial Activity and Resistance: Influencing Factors.Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo EfficaciesPharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducksImpact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infectionPharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica.Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection modelEmergence and spread of antibiotic resistance following exposure to antibiotics.Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal floraPharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach.Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves.Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives.Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model.
P2860
Q26753831-9546E160-FEAA-4A0A-9A65-4106F0F0DC67Q30911044-90E60857-FB0B-4AA0-AE8F-BEEEEF43EEE6Q33790192-54CC7D7D-4336-4F7C-B694-FDF3831597F6Q35823020-9CB6E7E8-611B-497C-A1E9-8AA83474784AQ36276123-B9761968-1365-4650-9A5F-BF1194E0E91DQ36401623-F09F95AE-726C-45A4-A8F3-897BE9FBBB6EQ36437749-9B5C0731-54E9-4521-A52A-087F493A2078Q36637193-75DDD9EF-C6AA-4C1C-9FCF-49A55DA09AE5Q37274635-D65E78E6-DE42-4D52-80FC-CE42A50FA91AQ37896674-B79F266F-BF06-4EFC-A03E-F60166773A58Q38324219-F0E4DCD7-BBC1-4538-83F5-27A755504B18Q39108922-81754CC9-B3F9-4530-BC7D-8BBAB960E267Q39261097-E742BAB6-2E2C-4AA9-A8F2-15C8574A66ABQ40106417-85DC0714-9C10-42E8-9BAB-C72AEB200275Q42612081-12F63023-F466-41BB-90DC-E99BAA7C087AQ42682745-E2B958DC-0D20-47D0-8D41-5BC717791615Q43988363-F4AF36DA-5AE9-4F98-BEB2-BBF6C464FC84Q46518946-553B6E37-4899-4E16-8178-CEFFA501001CQ47187274-293B5936-19EA-4F45-95C7-F21137AEBF59Q47774319-890CA1A0-9700-4E76-B0FD-104ED5DE2DC9Q54187518-A962B5A1-AE63-4EDE-A6DF-CA4B228D0C36
P2860
Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@en
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@nl
type
label
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@en
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@nl
prefLabel
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@en
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@nl
P2093
P2860
P356
P1476
Influence of inoculum size on ...... ncentrations of marbofloxacin.
@en
P2093
Alain Bousquet-Mélou
Aude Ferran
Pierre-Louis Toutain
Véronique Dupouy
P2860
P304
P356
10.1128/AAC.00156-07
P407
P577
2007-08-20T00:00:00Z